Opioid Prescribing and Opioid Use Disorder - WMG Orientation Session

INSTRUCTIONS - start here

Overview

This enduring material activity features content for WellSpan Medical Group physician/provider orientation, covering Opioid Prescribing and Opioid Use Disorder.

Expiration: This enduring material activity was published on November 17, 2020. This enduring material activity qualifies for AMA PRA Category 1 Credit (TM) for 25 months following its publication (until December 31, 2022).

Requirements: Read the overview, complete the Pre-Test, view the embedded video session, complete the Post-Test, and complete the evaluation form in order to receive credit for this activity. The post-test requires a score of 80% to pass with 3 attempts to successfully complete the post-test.

Disclosure: The planners and faculty for this activity have reported no financial disclosures.



Objectives

This enduring material activity features content for WellSpan Medical Group physician/provider orientation, covering Opioid Prescribing and Opioid Use Disorder.

Expiration: This enduring material activity was published on November 17, 2020. This enduring material activity qualifies for AMA PRA Category 1 Credit (TM) for 25 months following its publication (until December 31, 2022).

Requirements: Read the overview, complete the Pre-Test, view the embedded video session, complete the Post-Test, and complete the evaluation form in order to receive credit for this activity. The post-test requires a score of 80% to pass with 3 attempts to successfully complete the post-test.

Disclosure: The planners and faculty for this activity have reported no financial disclosures.


  1. Discuss Pennsylvania legal mandates regarding opioid prescribing.
  2. Describe approaches that WellSpan surgical teams have used to decrease opioid prescribing to decrease risk and enhance safety, while maintaining patient experience.
  3. Discuss the role of Medication Assisted Treatment (MAT) to enhance patient safety and decrease Opioid Use Disorder mortality.

Credits
AMA PRA Category 1 Credits™ (1.50 hours), Non-Physician Attendance (1.50 hours), Act 124 Opioid Continuing Education Qualified (1.50 hours)

Date & Location
Monday, November 23, 2020, 11:09 AM - Saturday, December 31, 2022, 11:30 PM

Accreditation

Accreditation Statement: WellSpan Health is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians. 

Credit Designation: WellSpan Health designates this Enduring Material activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All faculty participating in continuing medical education programs sponsored by WellSpan Health are expected to disclosure to the program audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s).


Target Audience
Specialties - Other
Professions - ALL